Relay Therapeutics, Inc.
RLAY
$7.75
$0.263.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.15M | -70.38M | -77.07M | -76.00M | -88.11M |
| Total Depreciation and Amortization | 748.00K | 1.00M | 1.21M | 1.33M | 1.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.78M | 16.02M | 17.73M | 15.35M | 19.31M |
| Change in Net Operating Assets | -3.50M | -1.91M | -15.08M | 1.45M | -7.65M |
| Cash from Operations | -62.12M | -55.26M | -73.21M | -57.87M | -75.08M |
| Capital Expenditure | 1.00K | -26.00K | -384.00K | 0.00 | -227.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.72M | 75.17M | 42.85M | 29.00M | -125.94M |
| Cash from Investing | 39.73M | 75.15M | 42.47M | 29.00M | -126.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.00K | 653.00K | -- | 800.00K | 218.89M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.00K | 653.00K | -- | 800.00K | 218.89M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.38M | 20.54M | -30.75M | -28.07M | 17.64M |